 |
市场调查报告书
商品编码
1181757
葡萄膜炎治疗市场：按治疗类型、按疾病类型、按分销渠道、按地区 - 规模、份额、展望、机会分析，2022-2030 年Uveitis Treatment Market, by Treatment Type, by Disease type, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 |
||||||
价格
简介目录
葡萄膜炎是眼睛葡萄膜的炎症。 葡萄膜是眼睛的中间层，由三部分组成：虹膜、睫状体和脉络膜。 葡萄膜炎是由多种因素引起的，包括炎症性疾病、眼外伤、病毒、细菌和真菌等微生物感染，以及接触强酸和杀虫剂等有毒化学品。 然而，在许多情况下，这种症状的原因仍然未知。 此外，已发现属于 20-50 岁年龄组的人受到影响。 根据葡萄膜发炎的部位分为三种类型，包括前葡萄膜炎，这是最常见的虹膜炎症。
市场动态
预计在预测期内，市场参与者推出更多产品将推动全球葡萄膜炎治疗市场。 例如，2022 年 2 月 7 日，总部位于佐治亚州、专门从事眼科处方药商业化和开发的生物製药公司 Alimera Sciences 在西班牙宣布推出用于葡萄膜炎的 ILUVIEN（fluocino）和 Ronacetonide（玻璃体内註射）。 ILUVIEN在欧洲获批用于预防因慢性糖尿病性黄斑水肿（DME）和后段非感染性葡萄膜炎（NIPU）引起的视力丧失復发，目前治疗被认为是不充分的。它是一种缓释眼内留置注射剂. ILUVIEN 是一个为期 36 个月的亚微克氟轻鬆丙酮疗程，这是一种皮质类固醇，可帮助患者更长时间地保持视力。
这项研究的主要特点
- 本报告对全球葡萄膜炎药物市场进行了深入分析，提供了以 2021 年为基准年的预测期（2022-2030 年）的市场规模和復合年增长率 (CAGR%)。
- 它揭示了不同细分市场的潜在收入机会，并描述了该市场具有吸引力的投资建议矩阵。
- 它还提供了有关市场驱动因素、制约因素、机会、新产品发布和批准、市场趋势、区域前景以及主要参与者采用的竞争战略的重要见解。
- 根据公司亮点、产品组合、主要亮点、财务业绩和战略等参数介绍全球葡萄膜炎治疗市场主要参与者的概况。
- 本研究涵盖的主要公司包括 AbbVie、Novartis AG、Bausch Health Companies Inc.、Galapagos NV、EyePoint Pharmaceuticals, Inc.、Clearside Biomedical、Tarsier Pharma Ltd、Santen Pharmaceutical Co., Ltd.、Bausch & Lomb Incorporated, Sanofi and Regeneron Pharmaceuticals, Inc., Alimera Sciences
- 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。我猜。
- 《全球葡萄膜炎治疗药物市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
- 利益相关者可以通过用于分析全球葡萄膜炎治疗市场的各种战略矩阵来促进决策制定。
内容
第 1 章目的和先决条件
- 调查目的
- 先决条件
- 缩写说明
第二章市场展望
- 报告内容
- 市场定义和范围
- 执行摘要
- 市场概况：按治疗类型分类
- 按疾病类型划分的市场概况
- 市场概况：按销售渠道
- 市场概况：按地区
- 连贯机会图 (COM)
第3章市场动态、规律及趋势分析
- 市场动态
- 司机
- 约束因素
- 市场机会
- 影响分析
- 市场趋势
- 近期趋势
- 收购和合作场景
- 技术概述
- 监管场景
- 管道分析
- 害虫分析
第 4 章全球葡萄膜炎药物市场 - 冠状病毒 (COVID-19) 大流行的影响
- 总体影响
- 对供需的影响
- COVID-19 对市场的影响
第 5 章全球葡萄膜炎药物市场：按治疗类型分类，2017-2030
- 肾上腺皮质类固醇
- 免疫抑製剂
- 单克隆抗体
- Cycloprenetic 药物
- 抗生素
- 抗病毒剂
- 抗真菌剂
- 抗生素
- 止痛药
第 6 章按疾病类型划分的葡萄膜炎药物全球市场，2017-2030
- 前葡萄膜炎
- 后葡萄膜炎
- 中间葡萄膜炎
- 全葡萄膜炎
第 7 章全球葡萄膜炎药物市场：按分销渠道，2017-2030
- 医院药房
- 零售药房
- 在线药店
- 药店
第 8 章 2017-2030 年按地区分列的全球葡萄膜炎药物市场
- 北美
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲地区
- 欧洲
- 英国
- 德国
- 意大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲地区
- 亚太地区
- 中国
- 印度
- 日本
- 东盟
- 澳大利亚
- 韩国
- 其他亚太地区
- 中东
- 海湾合作委员会
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中非
- 南非
第9章竞争格局
- AbbVie
- Novartis AG
- Bausch Health Companies Inc.
- Galapagos NV
- EyePoint Pharmaceuticals, Inc.
- Clearside Biomedical
- Tarsier Pharma Ltd
- Santen Pharmaceutical Co., Ltd.
- Bausch & Lomb Incorporated
- Sanofi
- Regeneron Pharmaceuticals, Inc.
- Alimera Sciences
第 10 章
- 调查方法
- 关于出版商
简介目录
Product Code: CMI1094
Uveitis refers to inflammation caused in the uvea of the eye. A uvea is the middle layer of the eye that consists of three components namely iris, cilliary body, and the choroid. Uveitis is caused by various factors such as inflammatory diseases, injuries in the eye, microbial infections such as viral, bacterial, and fungal infection or exposure to certain toxic chemicals such as strong acids or pesticides. However, in many cases the cause of this condition remains unknown. It is also found to be effecting people belonging to the age group of 20-50 years. The condition is classified based on the location of inflammation in the uvea and is categorized in three types including anterior uveitis that causes inflammation in the iris and is the most commonly encountered type.
Market Dynamics
Increasing product launches by market players is expected to drive the global uveitis treatment market over the forecast period. For instance, in February 7, 2022, Alimera Sciences which is a biopharmaceutical company based in Georgia that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals, has announced that it has announced Launch of ILUVIEN (fluocinolone acetonide intravitreal implant) for Uveitis in Spain. ILUVIEN is a sustained release intravitreal implant approved for use in Europe to treat vision loss brought on by chronic diabetic macular edema (DME), which is thought to be under responsive to current treatments, as well as to prevent relapse in cases of recurrent non-infectious uveitis affecting the posterior segment of the eye (NIPU). ILUVIEN is made to deliver sub-microgram quantities of the corticosteroid fluocinolone acetonide for 36 months, which helps patients preserve their vision for longer between treatments.
Key features of the study:
- This report provides in-depth analysis of the global uveitis treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global uveitis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include AbbVie, Novartis AG, Bausch Health Companies Inc., Galapagos NV, EyePoint Pharmaceuticals, Inc., Clearside Biomedical, Tarsier Pharma Ltd, Santen Pharmaceutical Co., Ltd., Bausch & Lomb Incorporated, Sanofi and Regeneron Pharmaceuticals, Inc., Alimera Sciences
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global uveitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global uveitis treatment market
Detailed Segmentation:
- Global Uveitis Treatment Market, By Treatment Type:
- Corticosteroids
- Immunosuppressant
- Monoclonal Antibodies
- Cycloplegic Agents
- Antibiotics
- Antivirals
- Antifungal
- Analgesics
- Global Uveitis Treatment Market, By Disease Type:
- Anterior Uveitis
- Posterior Uveitis
- Intermediate Uveitis
- Pan uveitis
- Global Uveitis Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
- Global Uveitis Treatment Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- AbbVie
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Bausch Health Companies Inc.
- Galapagos NV
- EyePoint Pharmaceuticals, Inc.
- Clearside Biomedical
- Tarsier Pharma Ltd
- Santen Pharmaceutical Co., Ltd.
- Bausch & Lomb Incorporated
- Sanofi
- Regeneron Pharmaceuticals, Inc.
- Alimera Sciences
- AbbVie
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Disease Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pipeline Analysis
- PEST Analysis
4. Global Uveitis Treatment Market- Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact
- Impact on Supply and Demand
- COVID-19 Impact on the market
5. Global Uveitis Treatment Market, By Treatment Type, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Immunosuppressant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Monoclonal Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Cycloplegic Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Antivirals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Antifungal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Analgesics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
6. Global Uveitis Treatment Market, By Disease Type, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Anterior Uveitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Posterior Uveitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Intermediate Uveitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Pan uveitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
7. Global Uveitis Treatment Market, By Distribution Channel, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Drug Stores
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
8. Global Uveitis Treatment Market, By Region, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- AbbVie
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bausch Health Companies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Galapagos NV
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- EyePoint Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Clearside Biomedical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Tarsier Pharma Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Santen Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bausch & Lomb Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Regeneron Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alimera Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
10. Section
- Research Methodology
- About Us
